Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Spironolactone helps regrow hair in women with hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

High androgen levels in young women with PCOS are linked to higher blood pressure.